Christoforos Thomas

1.6k total citations · 1 hit paper
30 papers, 1.3k citations indexed

About

Christoforos Thomas is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Christoforos Thomas has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Christoforos Thomas's work include Estrogen and related hormone effects (10 papers), Cancer-related Molecular Pathways (7 papers) and HER2/EGFR in Cancer Research (6 papers). Christoforos Thomas is often cited by papers focused on Estrogen and related hormone effects (10 papers), Cancer-related Molecular Pathways (7 papers) and HER2/EGFR in Cancer Research (6 papers). Christoforos Thomas collaborates with scholars based in United States, Greece and Sweden. Christoforos Thomas's co-authors include Jan-Ακε Gustafsson, Fotis Nikolos, Igor Bado, Anders Ström, Vidal Fey, Karolina Lindberg, M.L. Rothenberg, Yair Gazitt, Susan G. Hilsenbeck and Stuart E. Dryer and has published in prestigious journals such as Nature reviews. Cancer, Cancer Research and Oncogene.

In The Last Decade

Christoforos Thomas

28 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The different roles of ER subtypes in cancer biology and therapy

2011 525 citations Christoforos Thomas, Jan-Ακε Gustafsson Nature reviews. Cancer profile →

Peers

Christoforos Thomas

GENET

ONCOL

PRM

Joan Lewis-Wambi United States

Kerrie B. Bouker United States

Michelle W. Wong‐Brown Australia

Debra A. Tonetti United States

Renate M.L. Zwijsen Netherlands

Ashwini L. Chand Australia

Lih‐Ching Hsu Taiwan

Kin Chan Hong Kong

Adriana De Siervi Argentina

Joan Lewis-Wambi United States

Christoforos Thomas

631 ×0.9

471 ×1.0

GENET

424 ×0.9

ONCOL

323 ×1.3

129 ×1.1

PRM

Citations per year, relative to Christoforos Thomas Christoforos Thomas (= 1×) peers Joan Lewis-Wambi

Countries citing papers authored by Christoforos Thomas

Since Specialization

Citations

This map shows the geographic impact of Christoforos Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoforos Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoforos Thomas more than expected).

Fields of papers citing papers by Christoforos Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoforos Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoforos Thomas. The network helps show where Christoforos Thomas may publish in the future.

Co-authorship network of co-authors of Christoforos Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Christoforos Thomas. A scholar is included among the top collaborators of Christoforos Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoforos Thomas. Christoforos Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tastsoglou, Spyros, et al.. (2026). Estrogen receptor β target gene expression reveals novel repressive functions in aggressive breast cancer. npj Breast Cancer. 12(1).

Nandi, Ajeya, Anupma Nayak, Tsun Ki Jerrick To, et al.. (2022). Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer. Cancer Research. 82(20). 3718–3733. 27 indexed citations

Thomas, Christoforos, Ilias V. Karagounis, Nicholas Vrettos, et al.. (2021). Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer. Cancer Research. 81(9). 2399–2414. 11 indexed citations

Chao, Hann‐Hsiang, Ilias V. Karagounis, Christoforos Thomas, et al.. (2020). Combination of CHEK1/2 inhibition and ionizing radiation results in abscopal tumor response through increased micronuclei formation. Oncogene. 39(22). 4344–4357. 24 indexed citations

Karagounis, Ilias V., Stefano Pierini, Christoforos Thomas, et al.. (2020). Abstract 6509: Hypofractionated radiotherapy as a vaccine in combination with the TLR7/8 agonist resiquimod leads to significant abscopal tumor response and persistence antitumor immunity. Cancer Research. 80(16_Supplement). 6509–6509. 1 indexed citations

Kumar, Sushil, Ratnesh Kumar Srivastav, Srinivas Chatla, et al.. (2018). Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer. Oncogene. 38(12). 2092–2107. 73 indexed citations

Nikolos, Fotis, Christoforos Thomas, Igor Bado, & Jan-Ακε Gustafsson. (2017). ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response. Molecular Cancer Research. 16(2). 233–242. 16 indexed citations

Bado, Igor, Fotis Nikolos, Wanfu Wu, et al.. (2017). Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis. Breast Cancer Research. 19(1). 79–79. 20 indexed citations

Thomas, Christoforos, et al.. (2016). Estrogen signaling and unfolded protein response in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 163. 45–50. 19 indexed citations

10.

Bado, Igor, et al.. (2016). ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function. Oncotarget. 7(12). 13599–13611. 37 indexed citations

11.

Thomas, Christoforos & Jan-Ακε Gustafsson. (2015). Progesterone receptor-estrogen receptor crosstalk: a novel insight. Trends in Endocrinology and Metabolism. 26(9). 453–454. 26 indexed citations

12.

Thomas, Christoforos & Jan-Ακε Gustafsson. (2015). Estrogen receptor mutations and functional consequences for breast cancer. Trends in Endocrinology and Metabolism. 26(9). 467–476. 64 indexed citations

13.

Nikolos, Fotis, et al.. (2014). ERβ Regulates NSCLC Phenotypes by Controlling Oncogenic RAS Signaling. Molecular Cancer Research. 12(6). 843–854. 16 indexed citations

14.

Nikolos, Fotis, et al.. (2014). ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway. Oncogene. 34(31). 4130–4141. 44 indexed citations

15.

Thomas, Christoforos & Jan-Ακε Gustafsson. (2011). The different roles of ER subtypes in cancer biology and therapy. Nature reviews. Cancer. 11(8). 597–608. 525 indexed citations breakdown →

16.

Thomas, Christoforos, Anders Ström, Karolina Lindberg, & Jan-Ακε Gustafsson. (2010). Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling. Breast Cancer Research and Treatment. 127(2). 417–427. 44 indexed citations

17.

Thomas, Christoforos, Savvas Christoforidis, Panagiotis Kanavaros, et al.. (2009). Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27Kip1-dependent G1/S cell cycle arrest in conjunction with NF-κB activation. Biochemical Pharmacology. 78(1). 33–44. 28 indexed citations

18.

Nikas, Dimitrios, Anna Kotsia, Christoforos Thomas, et al.. (2008). Effect of intravenous administration of antioxidants alone and in combination on myocardial reperfusion injury in an experimental pig model. Current Therapeutic Research. 69(5). 423–439. 10 indexed citations

19.

Karamanakos, Petros N., Periklis Pappas, Vassiliki A. Boumba, et al.. (2007). Pharmaceutical Agents Known to Produce Disulfiram-Like Reaction: Effects on Hepatic Ethanol Metabolism and Brain Monoamines. International Journal of Toxicology. 26(5). 423–432. 38 indexed citations

20.

Gazitt, Yair, et al.. (1998). Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cells.. International Journal of Oncology. 13(4). 839–48. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact